CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,050 | +13.0% | 2,491 | +96.0% | 0.00% | – |
| Q1 2023 | $6,241 | -80.6% | 1,271 | -57.5% | 0.00% | -100.0% |
| Q4 2022 | $32,091 | +14.7% | 2,988 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $27,968 | +2.5% | 2,988 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $27,280 | -24.9% | 2,988 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $36,304 | -75.5% | 2,988 | -75.4% | 0.00% | -50.0% |
| Q4 2021 | $147,938 | -28.1% | 12,146 | -8.9% | 0.00% | -33.3% |
| Q3 2021 | $205,887 | +8.3% | 13,326 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $190,162 | -31.8% | 13,326 | +3.7% | 0.00% | -25.0% |
| Q1 2021 | $278,887 | +43.5% | 12,846 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $194,360 | +18.9% | 12,846 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $163,465 | -25.6% | 12,846 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $219,667 | +29.4% | 12,846 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $169,696 | -14.7% | 12,846 | +4.0% | 0.00% | +33.3% |
| Q4 2019 | $198,975 | -17.7% | 12,351 | -6.6% | 0.00% | -25.0% |
| Q3 2019 | $241,662 | -1.2% | 13,220 | +16.2% | 0.00% | 0.0% |
| Q2 2019 | $244,541 | +9.6% | 11,374 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $223,158 | +50.9% | 11,374 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $147,862 | -99.9% | 11,374 | +31.0% | 0.00% | 0.0% |
| Q2 2018 | $166,318,000 | +54.7% | 8,685 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $107,521,000 | +101334.9% | 8,685 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $106,000 | -53.3% | 8,685 | -47.6% | 0.00% | 0.0% |
| Q3 2017 | $227,000 | -11.0% | 16,569 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $255,000 | -16.4% | 16,569 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $305,000 | +35.6% | 16,569 | +23.9% | 0.00% | 0.0% |
| Q4 2015 | $225,000 | +26.4% | 13,370 | +7.4% | 0.00% | +100.0% |
| Q3 2015 | $178,000 | – | 12,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |